TY - JOUR AU - Harbeck, N. AU - Gnant, M. PY - 2017 DA - 2017// TI - Breast cancer JO - Lancet VL - 389 UR - https://doi.org/10.1016/S0140-6736(16)31891-8 DO - 10.1016/S0140-6736(16)31891-8 ID - Harbeck2017 ER - TY - JOUR AU - Fan, L. AU - Strasser-Weippl, K. AU - Li, J. J. PY - 2014 DA - 2014// TI - Breast cancer in China JO - Lancet Oncol VL - 15 UR - https://doi.org/10.1016/S1470-2045(13)70567-9 DO - 10.1016/S1470-2045(13)70567-9 ID - Fan2014 ER - TY - JOUR AU - Wu, T. AU - Dai, Y. PY - 2017 DA - 2017// TI - Tumor microenvironment and therapeutic response JO - Cancer Lett VL - 387 UR - https://doi.org/10.1016/j.canlet.2016.01.043 DO - 10.1016/j.canlet.2016.01.043 ID - Wu2017 ER - TY - JOUR AU - Katheder, N. S. AU - Khezri, R. AU - O’Farrell, F. PY - 2017 DA - 2017// TI - Microenvironmental autophagy promotes tumour growth JO - Nature VL - 541 UR - https://doi.org/10.1038/nature20815 DO - 10.1038/nature20815 ID - Katheder2017 ER - TY - JOUR AU - Komohara, Y. AU - Jinushi, M. AU - Takeya, M. PY - 2014 DA - 2014// TI - Clinical significance of macrophage heterogeneity in human malignant tumors JO - Cancer Sci VL - 105 UR - https://doi.org/10.1111/cas.12314 DO - 10.1111/cas.12314 ID - Komohara2014 ER - TY - JOUR AU - Zhao, X. AU - Qu, J. AU - Sun, Y. PY - 2017 DA - 2017// TI - Prognostic significance of tumor-associated macrophages in breast cancer: a meta-analysis of the literature JO - Oncotarget VL - 8 ID - Zhao2017 ER - TY - JOUR AU - Choi, J. AU - Gyamfi, J. AU - Jang, H. AU - Koo, J. S. PY - 2018 DA - 2018// TI - The role of tumor-associated macrophage in breast cancer biology JO - Histol Histopathol VL - 33 ID - Choi2018 ER - TY - JOUR AU - Tiainen, S. AU - Tumelius, R. AU - Rilla, K. PY - 2015 DA - 2015// TI - High numbers of macrophages, especially M2-like (CD163-positive), correlate with hyaluronan accumulation and poor outcome in breast cancer JO - Histopathology VL - 66 UR - https://doi.org/10.1111/his.12607 DO - 10.1111/his.12607 ID - Tiainen2015 ER - TY - JOUR AU - Fan, Q. M. AU - Jing, Y. Y. AU - Yu, G. F. PY - 2014 DA - 2014// TI - Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma JO - Cancer Lett VL - 352 UR - https://doi.org/10.1016/j.canlet.2014.05.008 DO - 10.1016/j.canlet.2014.05.008 ID - Fan2014 ER - TY - JOUR AU - Hollmen, M. AU - Roudnicky, F. AU - Karaman, S. AU - Detmar, M. PY - 2015 DA - 2015// TI - Characterization of macrophage–cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer JO - Sci Rep VL - 5 UR - https://doi.org/10.1038/srep09188 DO - 10.1038/srep09188 ID - Hollmen2015 ER - TY - JOUR AU - Feng, M. Y. AU - Chen, J. Y. AU - Weissman-Tsukamoto, R. PY - 2015 DA - 2015// TI - Macrophages eat cancer cells using their own calreticulin as a guide: roles of TLR and Btk JO - Proc Natl Acad Sci USA VL - 112 UR - https://doi.org/10.1073/pnas.1424907112 DO - 10.1073/pnas.1424907112 ID - Feng2015 ER - TY - JOUR AU - Vonderheide, R. H. PY - 2015 DA - 2015// TI - CD47 blockade as another immune checkpoint therapy for cancer JO - Nat Med VL - 21 UR - https://doi.org/10.1038/nm.3965 DO - 10.1038/nm.3965 ID - Vonderheide2015 ER - TY - JOUR AU - Zhang, L. AU - Huang, H. PY - 2016 DA - 2016// TI - Targeting the cancer biomarker CD47: a review on the diverse mechanisms of the CD47 pathway in cancer treatment JO - Anticancer Agents Med Chem VL - 16 UR - https://doi.org/10.2174/1871520615666151008123223 DO - 10.2174/1871520615666151008123223 ID - Zhang2016 ER - TY - JOUR AU - Chao, M. P. AU - Alizadeh, A. A. AU - Tang, C. PY - 2010 DA - 2010// TI - Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma JO - Cell VL - 142 UR - https://doi.org/10.1016/j.cell.2010.07.044 DO - 10.1016/j.cell.2010.07.044 ID - Chao2010 ER - TY - JOUR AU - Chao, M. P. AU - Alizadeh, A. A. AU - Tang, C. PY - 2011 DA - 2011// TI - Therapeutic antibody targeting of CD47 eliminates human acute lymphoblastic leukemia JO - Can Res VL - 71 UR - https://doi.org/10.1158/0008-5472.CAN-10-2238 DO - 10.1158/0008-5472.CAN-10-2238 ID - Chao2011 ER - TY - JOUR AU - Chan, K. S. AU - Espinosa, I. AU - Chao, M. PY - 2009 DA - 2009// TI - Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells JO - Proc Natl Acad Sci USA VL - 106 UR - https://doi.org/10.1073/pnas.0906549106 DO - 10.1073/pnas.0906549106 ID - Chan2009 ER - TY - JOUR AU - Baccelli, I. AU - Stenzinger, A. AU - Vogel, V. PY - 2014 DA - 2014// TI - Co-expression of MET and CD47 is a novel prognosticator for survival of luminal-type breast cancer patients JO - Oncotarget VL - 5 UR - https://doi.org/10.18632/oncotarget.2385 DO - 10.18632/oncotarget.2385 ID - Baccelli2014 ER - TY - JOUR AU - Kim, D. AU - Wang, J. AU - Willingham, S. B. PY - 2012 DA - 2012// TI - Anti-CD47 antibodies promote phagocytosis and inhibit the growth of human myeloma cells JO - Leukemia VL - 26 UR - https://doi.org/10.1038/leu.2012.141 DO - 10.1038/leu.2012.141 ID - Kim2012 ER - TY - JOUR AU - Xiao, Z. AU - Chung, H. AU - Banan, B. PY - 2015 DA - 2015// TI - Antibody mediated therapy targeting CD47 inhibits tumor progression of hepatocellular carcinoma JO - Cancer Lett VL - 360 UR - https://doi.org/10.1016/j.canlet.2015.02.036 DO - 10.1016/j.canlet.2015.02.036 ID - Xiao2015 ER - TY - JOUR AU - Casey, S. C. AU - Tong, L. AU - Li, Y. L. PY - 2016 DA - 2016// TI - MYC regulates the antitumor immune response through CD47 and PD-L1 JO - Science VL - 352 UR - https://doi.org/10.1126/science.aac9935 DO - 10.1126/science.aac9935 ID - Casey2016 ER - TY - JOUR AU - McCracken, M. N. AU - Cha, A. C. AU - Weissman, I. L. PY - 2015 DA - 2015// TI - Molecular pathways: activating T cells after cancer cell phagocytosis from blockade of CD47 “Don’t Eat Me” signals JO - Clin Cancer Res VL - 21 UR - https://doi.org/10.1158/1078-0432.CCR-14-2520 DO - 10.1158/1078-0432.CCR-14-2520 ID - McCracken2015 ER - TY - JOUR AU - Nagahara, M. AU - Mimori, K. AU - Kataoka, A. PY - 2010 DA - 2010// TI - Correlated expression of CD47 and SIRPA in bone marrow and in peripheral blood predicts recurrence in breast cancer patients JO - Clin Cancer Res VL - 16 UR - https://doi.org/10.1158/1078-0432.CCR-10-0349 DO - 10.1158/1078-0432.CCR-10-0349 ID - Nagahara2010 ER - TY - JOUR AU - Willingham, S. B. AU - Volkmer, J. P. AU - Gentles, A. J. PY - 2012 DA - 2012// TI - The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors JO - Proc Natl Acad Sci USA VL - 109 UR - https://doi.org/10.1073/pnas.1121623109 DO - 10.1073/pnas.1121623109 ID - Willingham2012 ER - TY - JOUR AU - Yoshida, K. AU - Tsujimoto, H. AU - Matsumura, K. PY - 2015 DA - 2015// TI - CD47 is an adverse prognostic factor and a therapeutic target in gastric cancer JO - Cancer Med VL - 4 UR - https://doi.org/10.1002/cam4.478 DO - 10.1002/cam4.478 ID - Yoshida2015 ER - TY - JOUR AU - Baccelli, I. AU - Schneeweiss, A. AU - Riethdorf, S. PY - 2013 DA - 2013// TI - Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay JO - Nat Biotechnol VL - 31 UR - https://doi.org/10.1038/nbt.2576 DO - 10.1038/nbt.2576 ID - Baccelli2013 ER - TY - JOUR AU - Bener, G. AU - Felix, A. J. AU - Sanchez de Diego, C. PY - 2016 DA - 2016// TI - Silencing of CD47 and SIRPalpha by polypurine reverse Hoogsteen hairpins to promote MCF-7 breast cancer cells death by PMA-differentiated THP-1 cells JO - BMC Immunol VL - 17 UR - https://doi.org/10.1186/s12865-016-0170-z DO - 10.1186/s12865-016-0170-z ID - Bener2016 ER - TY - JOUR AU - Kaur, S. AU - Elkahloun, A. G. AU - Singh, S. P. PY - 2016 DA - 2016// TI - A function-blocking CD47 antibody suppresses stem cell and EGF signaling in triple-negative breast cancer JO - Oncotarget VL - 7 UR - https://doi.org/10.18632/oncotarget.7100 DO - 10.18632/oncotarget.7100 ID - Kaur2016 ER - TY - JOUR AU - Manna, P. P. AU - Frazier, W. A. PY - 2004 DA - 2004// TI - CD47 mediates killing of breast tumor cells via Gi-dependent inhibition of protein kinase A JO - Cancer Res VL - 64 UR - https://doi.org/10.1158/0008-5472.CAN-03-1708 DO - 10.1158/0008-5472.CAN-03-1708 ID - Manna2004 ER - TY - JOUR AU - Zhang, H. AU - Lu, H. AU - Xiang, L. PY - 2015 DA - 2015// TI - HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells JO - Proc Natl Acad Sci USA VL - 112 UR - https://doi.org/10.1073/pnas.1520032112 DO - 10.1073/pnas.1520032112 ID - Zhang2015 ER - TY - JOUR AU - Bingle, L. AU - Brown, N. J. AU - Lewis, C. E. PY - 2002 DA - 2002// TI - The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies JO - J Pathol VL - 196 UR - https://doi.org/10.1002/path.1027 DO - 10.1002/path.1027 ID - Bingle2002 ER - TY - JOUR AU - Volodko, N. AU - Reiner, A. AU - Rudas, M. AU - Jakesz, R. PY - 1998 DA - 1998// TI - Tumour-associated macrophages in breast cancer and their prognostic correlations JO - Breast VL - 7 UR - https://doi.org/10.1016/S0960-9776(98)90065-0 DO - 10.1016/S0960-9776(98)90065-0 ID - Volodko1998 ER - TY - JOUR AU - Koelzer, V. H. AU - Canonica, K. AU - Dawson, H. PY - 2016 DA - 2016// TI - Phenotyping of tumor-associated macrophages in colorectal cancer: impact on single cell invasion (tumor budding) and clinicopathological outcome JO - Oncoimmunology VL - 5 UR - https://doi.org/10.1080/2162402X.2015.1106677 DO - 10.1080/2162402X.2015.1106677 ID - Koelzer2016 ER - TY - JOUR AU - Jaiswal, S. AU - Chao, M. P. AU - Majeti, R. AU - Weissman, I. L. PY - 2010 DA - 2010// TI - Macrophages as mediators of tumor immunosurveillance JO - Trends Immunol VL - 31 UR - https://doi.org/10.1016/j.it.2010.04.001 DO - 10.1016/j.it.2010.04.001 ID - Jaiswal2010 ER - TY - JOUR AU - Tlsty, T. D. AU - Coussens, L. M. PY - 2006 DA - 2006// TI - Tumor stroma and regulation of cancer development JO - Annu Rev Pathol VL - 1 UR - https://doi.org/10.1146/annurev.pathol.1.110304.100224 DO - 10.1146/annurev.pathol.1.110304.100224 ID - Tlsty2006 ER - TY - JOUR AU - Zaha, D. C. AU - Lazar, E. AU - Lazureanu, C. PY - 2010 DA - 2010// TI - Clinicopathologic features and five years survival analysis in molecular subtypes of breast cancer JO - Rom J Morphol Embryol VL - 51 ID - Zaha2010 ER - TY - JOUR AU - Denkert, C. PY - 2014 DA - 2014// TI - The immunogenicity of breast cancer–molecular subtypes matter JO - Ann Oncol VL - 25 UR - https://doi.org/10.1093/annonc/mdu235 DO - 10.1093/annonc/mdu235 ID - Denkert2014 ER - TY - JOUR AU - Gajewski, T. F. AU - Schreiber, H. AU - Fu, Y. X. PY - 2013 DA - 2013// TI - Innate and adaptive immune cells in the tumor microenvironment JO - Nat Immunol VL - 14 UR - https://doi.org/10.1038/ni.2703 DO - 10.1038/ni.2703 ID - Gajewski2013 ER - TY - JOUR AU - Junker, A. AU - Krumbholz, M. AU - Eisele, S. PY - 2009 DA - 2009// TI - MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47 JO - Brain VL - 132 UR - https://doi.org/10.1093/brain/awp300 DO - 10.1093/brain/awp300 ID - Junker2009 ER - TY - JOUR AU - Tang, W. AU - Qin, J. AU - Tang, J. PY - 2013 DA - 2013// TI - Aberrant reduction of MiR-141 increased CD47/CUL3 in Hirschsprung’s disease JO - Cell Physiol Biochem VL - 32 UR - https://doi.org/10.1159/000356601 DO - 10.1159/000356601 ID - Tang2013 ER - TY - JOUR AU - Suzuki, S. AU - Yokobori, T. AU - Tanaka, N. PY - 2012 DA - 2012// TI - CD47 expression regulated by the miR-133a tumor suppressor is a novel prognostic marker in esophageal squamous cell carcinoma JO - Oncol Rep VL - 28 UR - https://doi.org/10.3892/or.2012.1831 DO - 10.3892/or.2012.1831 ID - Suzuki2012 ER - TY - JOUR AU - Noman, M. Z. AU - Moer, K. AU - Marani, V. PY - 2018 DA - 2018// TI - CD47 is a direct target of SNAI1 and ZEB1 and its blockade activates the phagocytosis of breast cancer cells undergoing EMT JO - Oncoimmunology VL - 7 UR - https://doi.org/10.1080/2162402X.2017.1345415 DO - 10.1080/2162402X.2017.1345415 ID - Noman2018 ER -